Results 231 to 240 of about 35,534 (303)

Selective genome editing of amplified oncogenes triggers immunogenic cell death and tumor remodeling. [PDF]

Mol Cancer
Nieto-Sanchez A, Martinez-Lage M, Puig-Serra P, Carpintero S, Alonso-Yanez A, Ojeda-Walczuk P, Ibañez-Navarro M, Pita G, Moya FJ, Moreno C, Martin MC, Alonso R, Nuñez-Torres R, Sanchez-Arevalo Lobo VJ, Alonso-Guirado L, Malats N, Gonzalez-Neira A, Fernandez L, Roda-Navarro P, Torres-Ruiz R, Rodriguez-Perales S.   +20 more
europepmc   +1 more source

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma. [PDF]

Proc Natl Acad Sci U S A
Yuan J, Maitra S, Antoniou E, Zhu J, Li W, Demirel IS, Toskas K, Martinez IL, Ozcimen L, Lindehell H, Muhr J, Stenman J, Kogner P, Bedoya-Reina OC, Schlisio S, Holmberg J.   +15 more
europepmc   +1 more source

Differential module analysis in neuroblastoma regulatory networks [PDF]

, 2014
Beckers, Anneleen, Cannoodt, Robrecht, De Preter, Katleen, Saeys, Yvan, Van Cauwenbergh, Caroline   +4 more
core   +1 more source

Protocol to analyze changes in hippocampal neural stem cell quiescence from single-cell RNA sequencing data. [PDF]

STAR Protoc
Hart J, Harris L.
europepmc   +1 more source

MYCN-Driven Metabolic Networks Are a Critical Dependency of High-Risk Neuroblastomas. [PDF]

Cancers (Basel)
Pitts MG, Bryant LT, Buoncristiani MD, Rellinger EJ.   +3 more
europepmc   +1 more source

Trajectory analysis reveals an uncommitted neuroblastic state in MYCN-driven neuroblastoma development. [PDF]

Neuro Oncol
Tsubota S, Carter DR, Seneviratne JA, Hirose H, Shimamura T, Kashima Y, Suzuki Y, Tsuda K, Marshall GM, Kadomatsu K.   +9 more
europepmc   +1 more source

SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma. [PDF]

J Exp Clin Cancer Res
Liu Z, Bagchi S, Yan C, Hu Y, Blum G, Ma A, Jin J, Luo M, Di Bella S, Verona F, Appella E, Giannini G, Thiele CJ, Veschi V.   +13 more
europepmc   +1 more source

A computational model elucidates the effects of oncogene-induced expression alterations on the energy metabolism of neuroblastoma. [PDF]

Sci Rep
Simon M, Benary U, Baum K, Schramm A, Wolf J.   +4 more
europepmc   +1 more source

Expanding MYCN's Reach in Oncogenic Transcription [PDF]

JNCI Journal of the National Cancer Institute, 2015
openaire   +2 more sources

Targeting endoplasmic reticulum stress and nitroso-redox imbalance in neuroendocrine prostate cancer: the therapeutic role of nitric oxide. [PDF]

Cell Death Discov
Firdaus F, Napoles OC, Dulce RA, Edupuganti A, Kumar S, Shah K, Salihoglu S, Van Booven DJ, Gasca R, B Lombard D, Hare JM, Zhang F, Qureshi R, Arora H.   +13 more
europepmc   +1 more source